Dosimetric analysis of 3D-conformal radiotherapy and intensity modulated radiotherapy for treatment of advanced stage cervical cancer: A comparative study

Gangarapu Sri Krishna, Marella Venkata Ramireddy, Komanduri Ayyangar, Palreddy Yadagiri Reddy


Purpose: The purpose of this study is to analyze the dosimetric parameters of three dimensional conformal radiotherapy (3DCRT), intensity modulated radiotherapy (IMRT) with seven and nine fields (7F-IMRT, 9F-IMRT) in selected advanced stage cervical cancer cases.

Methods: Fifteen cases of cervical cancer (IIB to IIIB) were selected for retrospective analysis. All the cases were previously treated with 3DCRT technique with prescribed dose of 50 Gy in 25 fractions.  For this study, plans with seven fields IMRT and nine fields IMRT were generated for all patients following Radiation Therapy Oncology Group (RTOG) guidelines. The plans were compared on the basis of planning target volume (PTV) coverage (dose to 1%, 5%, 95% and 99% of target), maximum dose and mean dose to organs at risk (OARs) and also doses at different volumes of OARs. Apart from this, uniformity index (UI), homogeneity index (HI), conformity index (CI) and dose spillage index (R50%) were also calculated with respect to PTV coverage.

Results: The average dose value of PTV coverage for all three techniques were comparable and all the DVH indices for 7field IMRT (UI (1.04±0.01), HI (0.07 ±0.02), CI (0.75±0.03) and R50% (4.47±0.36)) were better than 3DCRT and 9F-IMRT techniques. All OAR doses were significantly reduced in 7F- IMRT compared to 3DCRT and 9F- IMRT. The target volumes ranged from 769.2 ml to 1375.6 ml with average target volume of 1071.9 ml (SD: 205.38 ml).

Conclusion: This study showed that significant dose reduction to OARs could be achieved with seven field IMRT plans by maintaining the PTV coverage compared to 3DCRT or 9F- IMRT for treating cervical cancer in advanced stages particularly from IIB to IIIB.


Three dimensional conformal radiotherapy, Intensity modulated radiotherapy, Organs at risk, Uniformity index, Conformity index, Homogeneity index, Dose spillage index.

Full Text:



Jemal A, Tiwari RC, Murray T, et al. Cancer statistics. Cancer J Clin. 2004;54:8-29.

Ferlay J, Shin HR, Bray F, et al. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer; 2010. GLOBOCAN 2008.

Roeske JC, Lujan A, Rotmensch J, et al. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys. 2000;48(5):1613–21.

Mundt AJ, Lujan AE, Rotmensch J, et al. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys. 2002;52(5):1330–7.

Mundt AJ, Roeske JC, Lujan AE. Intensity-modulated radiation therapy in gynecologic malignancies. Med Dosim. 2002;27(2):131–6.

Bloemers MC, Portelance L, Ruo R, et al. A dosimetric evaluation of dose escalation for the radical treatment of locally advanced vulvar cancer by intensity-modulated radiation therapy. Med Dosim. 2012;37(3):310-3.

Tyagi A, Supe SS, Sandeep, Singh MP. A dosimetric analysis of 6 MV versus 15 MV photon energy plans for intensity modulated radiation therapy (IMRT) of carcinoma of cervix. Rep Pract Oncol Radiother. 2010;15(5).

Lukovic J, Patil N, D'souza D, et al. Intensity-modulated radiation therapy versus 3d conformal radiotherapy for postoperative gynecologic cancer: are they covering the same planning target volume? Cureus. 2016;8(1).

Erpolat OP, Alco G, Caglar HB, et al. Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: a national multi-center study. Eur J Gynaecol Oncol. 2014;35(1):62-6.

Avinash HU, Arul Ponni TR, et al. A prospective dosimetric and clinical comparison of acute hematological toxicities in three-dimensional conformal radiation therapy and intensity modulated radiation therapy with concurrent chemotherapy in carcinoma cervix. J Cancer Res Ther. 2015;11(1):83-7.

Mounessi FS, Lehrich P, Haverkamp U, et al. Pelvic Ewing sarcomas. Three-dimensional conformal vs. intensity-modulated radiotherapy. Strahlenther Onkol. 2013;189(4):308-14.

Khosla D, Patel FD, Shukla AK, et al. Dosimetric evaluation and clinical outcome in post-operative patients of carcinoma vulva treated with intensity-modulated radiotherapy. Indian J Cancer. 2015;52(4):670-4.

Chan P, Yeo I, Perkins G, et al. Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study. Radiat Oncol. 2006;1:13.

Pathak P, Vashisht S. A quantitative analysis of intensity modulated radiation therapy plans and comparison of homogeneity indices for the treatment of gynecological cancers. J Med Phy. 2013;38(2):67-73.

Mahmoud M, EL-Hossiny HA, Diab NA, et al. Dosimetric study comparing intensity modulated and conformal pelvic radiotherapy boost plans in locally advanced cancer cervix in NCI-Cairo. The Chinese-German Journal of Clinical Oncology. 2013;12(6):293-6.

Cozzi L, Dinshaw KA, Shrivastava SK, et al. A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiother Oncol. 2008;89(2):180-91.

Ekambaram V, Velayudham R. Analysis of low dose level volumes in intensity modulated radiotherapy and 3-D conformal radiotherapy. Int J Cancer Ther Oncol. 2014;2(3):02032.

Ahmed RS, Kim RY, Duan J, et al. IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advancedcervical cancer while reducing dose to bone marrow and other organs at risk. Int J Radiat Oncol Biol Phys. 2004;60(2):505-12.

Dogan N, Cuttino L, Lloyd R, et al. Optimized dose coverage of regional lymph nodes in breast cancer: the role of intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2007;68(4):1238-50.

Muren LP, Redpath AT, McLaren D, et al. A concomitant tumour boost in bladder irradiation: patient suitability and the potential of intensity-modulated radiotherapy. Radiother oncol. 2006;80(1):98-105.

ICRU Report 83. Prescribing, recording, and re- porting photon-beam intensity-modulated radiation therapy (IMRT). International Commission on Radiation Units and Measurements, Bethesda; 2010.

Feuvret l, Noel G, Mazeron JJ, et al. Conformity index: A review. Int Radiat Oncol Biol Phys. 2006;64(2):333-42.

Knoos T, Kristensen I, Nilsson P. Volumetric and dissymmetric evaluation of radiation treatment plans: Radiation conformity index. Int J Radiat Oncol Biol Phys. 1998;42:1169-76.

Wang X, Zhang X, Dong L, et al. Effectiveness of noncoplanar IMRT planning using a parallelized multiresolution beam angle optimization method for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys. 2005;63(2):594-601.

Sheng K, Molloy JA, Larner JM, et al. A dosimetric comparison of non-coplanar IMRT versus Helical Tomotherapy for nasal cavity and paranasal sinus cancer. Radiother Oncol. 2007;82(2):174-8.

Nutting CM, Bedford JL, Cosgrove VP, et al. A comparison of conformal and intensity-modulated techniques for oesophageal radiotherapy. Radiother Oncol. 2001;61(2):157-63.

Kataria T, Sharma K, Subramani V, et al. Homogeneity Index: An objective tool for assessment of conformal radiation treatments. J Med Phys. 2012;37(4):207-13.

Pezner RD, Liu A, Han C, et al. Dosimetric comparison of helical tomotherapy treatment and step-and-shoot intensity-modulated radiotherapy of retroperitoneal sarcoma. Radiother Oncol. 2006;81(1):81-7.

Merrow CE, Wang IZ, Podgorsak MB. A dosimetric evaluation of VMAT for the treatment of non-small cell lung cancer. J Appl Clin Med Phys. 2012;14(1):4110.

Weyh A, Konski A, Nalichowski A, et al. Lung SBRT: Dosimetric and delivery comparison of RapidArc, TomoTherapy, and IMR. J Appl Clin Med Phys. 2013;14(4):4065.

Portelance L, Chao KS, Grigsby PW, et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in Patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys. 2001;51(1):261-6.


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.


International Journal of Cancer Therapy and Oncology (ISSN 2330-4049)

© International Journal of Cancer Therapy and Oncology (IJCTO)

To make sure that you can receive messages from us, please add the '' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.


Number of visits since October, 2013